NEW YORK, Feb. 25 (GenomeWeb News) - SAS has licensed its Scientific Discovery Solutions software to Gencell, the company said today.
Gencell, a subsidiary of Aventis Pharma, will use the package, including SAS Research Data Management, SAS Microarray Solution, and SAS Enterprise Miner, to analyze and manage gene expression data, to handle data from clinical trials, and to develop electronic filings to health authorities.
Last month, Bristol-Myers Squibb said it will test SAS software for gene expression analysis and proteomics.